AstraZeneca May Conduct Additional Trial For Covid-19 Vaccine After Acknowledging Errors In Initial Trial

The company’s CEO said the new trial will be conducted outside the U.S. and its data may not be adequate to lead to approval from the FDA.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive